An international team led by CFRI member Dr. Christopher Maxwell and his colleague Dr. Miguel Àngel Pujana of the Catalan Institute of Oncology describes a fundamental molecular mechanism in the development of breast cell epithelium that is altered in some breast cancer patients. Researchers have found a key in the interplay between two genes which represents a previously unknown molecular pathway. The results were published this week in the journal PLoS Biology.

[news release]    [journal article]